
RRPF, Patient-Led Listening Session with the FDA
On October 27, 2022, the Recurrent Respiratory Papillomatosis Foundation (RRPF) held a Patient-Led Listening Session with the FDA (Federal Drug Administration). We are excited to
With our voices united, we can and will work to end the burden of this disease on patients and caregivers.
The RRPF will work to transform the lives of patients with RRP by advocating for a paradigm shift toward non-surgical options by catalyzing innovation through education, research, and collaboration in addition to promoting HPV prevention.
With our voices united, we can and will work to end the burden of this disease on patients and caregivers.
Join the ongoing research in the CoRDS Study
(Coming Soon) A place for kids to connect with other kids living with RRP
See the latest articles about RRPF and our community
Join our community and find helpful information
Join our fight today.
We work tirelessly to provide the RRP Community with timely and helpful information about trials, treatments and anything else that can help our fight.
On October 27, 2022, the Recurrent Respiratory Papillomatosis Foundation (RRPF) held a Patient-Led Listening Session with the FDA (Federal Drug Administration). We are excited to
September 13, 2022, Blog Entry – fifth PRGN-2012 research study visit to the NIH. On September 6, 2022, I travelled to the NIH/Bethesda, MD. This